UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (date of earliest event reported): December 14, 2006
PEDIATRIX MEDICAL GROUP, INC.
(Exact Name of Registrant as Specified in Its Charter)
| |
|
|
|
|
| Florida
|
|
001-12111
|
|
65-0271219 |
|
|
|
|
|
|
(State or Other
Jurisdiction of
Incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
1301 Concord Terrace
Sunrise, Florida 33323
(Address of principal executive office)
Registrant’s telephone number, including area code (954) 384-0175
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On December 14, 2006, Pediatrix Medical Group, Inc. (the “Company”), certain of the
Company’s subsidiaries and affiliates (collectively with the Company, the “Borrowers”), Bank of
America, N.A. (the “Administrative Agent”), and each of the lenders signatory thereto entered into
a Consent to Extension Agreement (the “Consent”). Pursuant to Sections 6.01(b) and 6.02(b) of the
Credit Agreement dated as of July 30, 2004 among the Borrowers, the Administrative Agent and each
of the lenders signatory thereto as previously amended through the date hereof (the “Credit
Agreement”), the Company is required to deliver to the Administrative Agent quarterly financial
statements (the “Quarterly Financial Statements”) and a compliance certificate (the “Compliance
Certificate”) as soon as available, but in any event within 45 days after the end of each of the
first three fiscal quarters of the Company’s fiscal year. The Consent provides an extension of
time for the delivery of the Quarterly Financial Statements and Compliance Certificate required
for the fiscal quarters ended June 30, 2006 and September 30, 2006 until March 15, 2007 subject to
certain terms and conditions as set forth therein.
The foregoing description of the Consent does not purport to be complete and is qualified in
its entirety by reference to the full text of such Consent, a copy of which is filed as Exhibit
10.1 to this Current Report on Form 8-K and is incorporated herein by reference thereto.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits.
10.1 — Consent to Extension Agreement dated December 14, 2006.
2